tryptamine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, Y | 1 |
| Sakanishi, A | 1 |
| Matsuda, K | 1 |
| Hattori, M | 1 |
| Kaneko, I | 1 |
| Nishikawa, M | 1 |
| Ikushiro, S | 1 |
1 other study available for tryptamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Covalent adduction of serotonin-derived quinones to the SARS-CoV-2 main protease expressed in a cultured cell.
Topics: Cells, Cultured; Coronavirus 3C Proteases; COVID-19; Humans; Protease Inhibitors; Quinones; SARS-CoV | 2023 |